Vertex to Acquire Semma Therapeutics With a Goal of Developing Curative Cell-Based Treatments for Type 1 Diabetes Read more
An exclusive Aerie Pharmaceuticals speaker interview released for SMi’s Ophthalmic Drugs Conference 2019 Read more
Helsinn signs exclusive distribution and license agreements with Blanver and Varifarma for Pracinostat in South America Read more
Entresto improved measures of heart structure and function in HFrEF patients in new Novartis study; additional data complement findings Read more
Covance Launches Laboratory Data Management Functional Service Provider for Pharmaceutical and Biotechnology Customers Read more
Novartis PARAGON-HF trial suggests Entresto benefit in HFpEF patients but narrowly misses primary endpoint Read more